New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition

Akbulut,Gamze

doi:10.3892/etm.2011.247

New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition

Authors:
- Gamze Akbulut
View Affiliations

Affiliations: Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Besevler, Ankara, Turkey
Published online on: April 1, 2011 https://doi.org/10.3892/etm.2011.247
Pages: 675-684

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer and its treatment result in severe biochemical and physiological alterations associated with a deterioration of quality of life (QoL). Cancer-related malnutrition may evolve into cancer cachexia due to complex interactions between pro-inflammatory cytokines and the host metabolism. Depending on the type of cancer treatment (either curative or palliative), the clinical condition of the patient and nutritional status, adequate and patient-tailored nutritional intervention should be prescribed (diet counseling, oral supplementation, enteral or total parenteral nutrition). Nutritional support has been widely advocated as adjunctive therapy for a variety of underlying illnesses, including surgery and medical oncotherapy (radiation or chemotherapy for cancer). Glutamine, n-3 fatty acids and probiotics/prebiotics are therapeutic factors that potentially modulate gastrointestinal toxicity related to cancer treatments. Enteral and parenteral nutrition may help improve patient survival, functional status and QoL, yet the benefits appear to be primarily limited to patients with good functional status and with gastrointestinal disease affecting nutritional intake. Parenteral nutrition offers the possibility of increased or maintenance of the nutrient intake in patients for whom normal food intake is inadequate and for whom enteral nutrition is not feasible, is contraindicated or is not accepted by the patient. This article reviews evidence on issues relevant to enteral and parenteral nutrition in patients with cancer.

View Figures

View References

1.	Jones L, Watling RM, Wilkins S and Pizer B: Nutritional support in children and young people with cancer undergoing chemotherapy. Cochrane Database Syst Rev. 7:1–50. 2010.PubMed/NCBI
2.	Xue H, Sawyer MB, Wischmeyer PE and Baracos VE: Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. J Parenter Enteral Nutr. 35:74–90. 2011. View Article : Google Scholar : PubMed/NCBI
3.	Shike M: Nutrition therapy for the cancer patient. Hematol Oncol Clin North Am. 10:221–234. 1996. View Article : Google Scholar : PubMed/NCBI
4.	Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G and Muscaritoli M: ESPEN Guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 28:445–454. 2009. View Article : Google Scholar : PubMed/NCBI
5.	Morss S: Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care. 23:369–377. 2006. View Article : Google Scholar : PubMed/NCBI
6.	Muscaritoli M, Bossola R, Bellantone R and Fanelli FR: Therapy of muscle wasting in cancer: what is the future? Curr Opin Clin Nutr Metab Care. 7:459–466. 2004. View Article : Google Scholar : PubMed/NCBI
7.	Simons JPFHA, Schols AM, Buurman WA and Wouters EF: Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci. 97:215–223. 1999. View Article : Google Scholar
8.	Barber MD: The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract. 17:203–209. 2002. View Article : Google Scholar : PubMed/NCBI
9.	Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer. 11:862–871. 2002. View Article : Google Scholar : PubMed/NCBI
10.	Arends J: Metabolism in cancer patients. Anticancer Res. 30:1863–1868. 2010.
11.	Van Cutsem E and Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 9(Suppl. 2): 51–63. 2005.PubMed/NCBI
12.	Jatoi A, Daly BD, Hughes VA, Dallal GE, Kehayias J and Roubenoff R: Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg. 72:348–351. 2001. View Article : Google Scholar : PubMed/NCBI
13.	Argilés JM, Olivan M, Busquets S and López-Soriano FJ: Optimal management of cancer anorexia-cachexia syndrome. Cancer Manag Res. 22:27–38. 2010.
14.	Nitenberg G and Raynard B: Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol. 34:137–168. 2000. View Article : Google Scholar : PubMed/NCBI
15.	Drudge-Coates L: Improving management of patients with advanced cancer. Patient Prefer Adherence. 2:415–424. 2010. View Article : Google Scholar
16.	Marín Caro MM, Laviano A and Pichard C: Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 26:289–301. 2007.PubMed/NCBI
17.	Ströhle A, Zänker K and Hahn A: Nutrition in oncology: the case of micronutrients (Review). Oncol Rep. 24:815–828. 2010.PubMed/NCBI
18.	Marín Caro MM, Laviano A and Pichard C: Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care. 10:480–487. 2007.PubMed/NCBI
19.	Tian J and Chen JS: Nutritional status and quality of life of the gastric cancer patients in Changle County of China. World J Gastroenterol. 11:1582–1586. 2005. View Article : Google Scholar : PubMed/NCBI
20.	Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG and Lammersfeld CA: Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol. 59:704–709. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Ravasco P, Monteiro-Grillo I, Vidal PM and Camilo ME: Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer. 12:246–252. 2004.
22.	Petruson KM, Silander EM and Hammerlid EB: Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck. 27:302–310. 2005. View Article : Google Scholar : PubMed/NCBI
23.	Bower M, Jones W, Vessels B, Scoggins C and Martin R: Role of esophageal stents in the nutrition support of patients with esophageal malignancy. Nutr Clin Pract. 25:244–249. 2010. View Article : Google Scholar : PubMed/NCBI
24.	Marín Caro MM, Gómez Candela C, Castillo Rabaneda R, Lourenço Nogueira T, García Huerta M and Loria Kohen V: [Nutritional risk evaluation and establishment of nutritional support in oncology patients according to the protocol of the Spanish Nutrition and Cancer Group]. Nutr Hosp. 23:458–468. 2008.
25.	Mudigonda T and Mudigonda P: Palliative cancer care ethics: principles and challenges in the Indian setting. Indian J Palliat Care. 16:107–110. 2010. View Article : Google Scholar : PubMed/NCBI
26.	Maree JE and Wright SC: Palliative care: a positive outcome for cancer patients? Curationis. 31:43–49. 2008. View Article : Google Scholar : PubMed/NCBI
27.	Granda-Cameron C, Viola SR, Lynch MP and Polomano RC: Measuring patient-oriented outcomes in palliative care: functionality and quality of life. Clin J Oncol Nurs. 12:65–77. 2008. View Article : Google Scholar : PubMed/NCBI
28.	Wiseman M: The treatment of oral problems in the palliative patient. J Can Dent Assoc. 72:453–458. 2006.PubMed/NCBI
29.	Koretz RL: Should patients with cancer be offered nutritional support: Does the benefit outweigh the burden? Eur J Gastroenterol Hepatol. 19:379–382. 2007. View Article : Google Scholar : PubMed/NCBI
30.	Arends J, Bodoky G, Bozzetti F, et al: ESPEN Guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 25:245–259. 2006. View Article : Google Scholar : PubMed/NCBI
31.	ASPEN Board of Directors: Clinical Guidelines Task Force, Nutrition assessment – adults. J Parenter Enteral Nutr. 26:9–12. 2002.
32.	Sax HC and Souba WW: Enteral and parenteral feedings. Guidelines and recommendations. Med Clin North Am. 77:863–880. 1993.PubMed/NCBI
33.	Hardman WE: Omega-3 FA to augment cancer therapy. J Nutr. 132(Suppl. 11): 35082002.PubMed/NCBI
34.	Hardman WE: N-3 fatty acids and cancer therapy. J Nutr. 134(Suppl. 12): 3427–3430. 2004.PubMed/NCBI
35.	Caughey GE, Mantzioris E, Gibson RA, Cleland LG and James MJ: The effect on human tumor necrosis factor alpha and interleukin 1beta production of diets enriched in or fish oil. Am J Clin Nutr. 63:116–119. 1996.PubMed/NCBI
36.	Barber MD: Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation. Nutrition. 17:751–755. 2001. View Article : Google Scholar : PubMed/NCBI
37.	Moses AW, Slater C, Preston T, Barber MD and Fearon KC: Reduced total energy expenditure and physical activity in cachexia patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 90:996–1002. 2004. View Article : Google Scholar
38.	Takatsuka H, Takemoto Y and Iwata N: Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant. 28:769–774. 2001. View Article : Google Scholar : PubMed/NCBI
39.	Bruera E, Strasser F and Palmer JL: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 21:129–134. 2003. View Article : Google Scholar : PubMed/NCBI
40.	Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC and Fearon KC: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 12(Suppl. 1): 27–30. 1996. View Article : Google Scholar : PubMed/NCBI
41.	Bauer JD and Capra S: Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy – a pilot study. Support Care Cancer. 213:270–274. 2005.PubMed/NCBI
42.	Fearon KC, von Meyenfeldt MF, Moses AG, et al: Effect of a protein and energy dense n-3 fatty acid-enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 52:1479–1486. 2003. View Article : Google Scholar : PubMed/NCBI
43.	Read JA, Beale PJ, Volker DH, Smith N, Childs A and Clarke SJ: Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 15:301–307. 2007. View Article : Google Scholar
44.	Spencer L, Mann C, Metcalfe M, Webb M, Pollard C and Spencer D: The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer. 45:2077–2086. 2009. View Article : Google Scholar : PubMed/NCBI
45.	Fritsche KL: Are omega-3 fatty acids effective in enhancing tumoricidal cell activity? J Nutr. 135:2916–2917. 2005.
46.	Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ and Zandstra DF: Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 27:84–90. 2001.PubMed/NCBI
47.	Berg A, Rooyackers O, Norberg A and Wernerman J: Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids. 29:221–228. 2005. View Article : Google Scholar : PubMed/NCBI
48.	Darmaun D: Role of glutamine depletion in severe illness. Diabetes Nutr Metab. 13:25–30. 2000.PubMed/NCBI
49.	Ziegler TR, Bazargan N and Galloway JR: Glutamine enriched parenteral nutrition; saving nitrogen and saving money? Clin Nutr. 19:375–377. 2000. View Article : Google Scholar : PubMed/NCBI
50.	Novak F, Heyland DK, Avenell A, Drover JW and Su X: Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 30:2022–2029. 2002. View Article : Google Scholar : PubMed/NCBI
51.	Goeters C, Wenn A, Mertes N, et al: Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 30:2032–2037. 2002. View Article : Google Scholar : PubMed/NCBI
52.	Wernerman J: Clinical use of glutamine supplementation. J Nutr. 138:2040–2044. 2008.PubMed/NCBI
53.	Crowther M, Avenell A and Culligan DJ: Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplant. 44:413–425. 2009. View Article : Google Scholar : PubMed/NCBI
54.	Ziegler TR: Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy. J Nutr. 131:2578–2584. 2001.PubMed/NCBI
55.	Blijlevens NMA, Donnelly JP and De Pauw BE: Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant. 25:1269–1278. 2000. View Article : Google Scholar
56.	Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E and Rubenstein EB: The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 98:1531–1539. 2003. View Article : Google Scholar : PubMed/NCBI
57.	Sonis ST, Oster G, Fuchs H, et al: Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 19:2201–2205. 2001.PubMed/NCBI
58.	Kuskonmaz B, Yalcin S, Kucukbayrak O, et al: The effect of glutamine supplementation on hematopoietic stem cell transplant outcome in children: a case-control study. Pediatr Transplant. 12:47–51. 2008. View Article : Google Scholar : PubMed/NCBI
59.	Aquino VM, Harvey AR, Garvin JH, et al: A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant. 36:611–616. 2005. View Article : Google Scholar
60.	Ziegler TR: Glutamine supplementation in bone marrow transplantation. Br J Nutr. 87(Suppl. 1): 9–15. 2002. View Article : Google Scholar : PubMed/NCBI
61.	Wilmore DW, Schloerb PR and Ziegler TR: Glutamine in the support of patients following bone marrow transplantation. Curr Opin Clin Nutr Metab Care. 2:323–327. 1999. View Article : Google Scholar : PubMed/NCBI
62.	Arfons LM and Lazarus HM: Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo? Bone Marrow Transplant. 36:281–288. 2005. View Article : Google Scholar : PubMed/NCBI
63.	Whelan K and Schneider SM: Mechanisms, prevention, and management of diarrhea in enteral nutrition. Curr Opin Gastroenterol. 27:152–159. 2011. View Article : Google Scholar : PubMed/NCBI
64.	Whelan K: Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics. Proc Nutr Soc. 66:299–306. 2007. View Article : Google Scholar : PubMed/NCBI
65.	De Preter V, Hamer HM, Windey K and Verbeke K: The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res. 55:46–57. 2011.
66.	Pagnini C, Corleto VD, Hoang SB, Saeed R, Cominelli F and Delle Fave G: Commensal bacteria and ‘oncologic surveillance’: suggestions from an experimental model. J Clin Gastroenterol. 42:S193–S196. 2008.
67.	Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT and Cominelli F: Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA. 107:454–459. 2010. View Article : Google Scholar : PubMed/NCBI
68.	Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R and Rowland I: Prebiotic effects: metabolic and health benefits. Br J Nutr. 104(Suppl. 2): 1–63. 2010. View Article : Google Scholar : PubMed/NCBI
69.	Santacroce L, Leone D, Valenzano A, Luperto P, Bottalico L and Losacco T: Nutritional problems in the surgical patients with head and neck tumours. Literature review and personal experience. Clin Ter. 156:227–230. 2005.(In Italian).
70.	Huhmann MB and August DA: Nutrition support in surgical oncology. Nutr Clin Pract. 24:520–526. 2009. View Article : Google Scholar : PubMed/NCBI
71.	Huhmann MB and August DA: Review of American Society for Parenteral and Enteral Nutrition (ASPEN) clinical guidelines for nutrition support in cancer patients: nutrition screening and assessment. Nutr Clin Pract. 23:182–188. 2008. View Article : Google Scholar
72.	Senesse P, Assenat E, Schneider S, Chargari C, Magné N and Azria D: Nutritional support during oncologic treatment of patients with gastrointestinal cancer: Who could benefit? Cancer Treat Rev. 34:568–575. 2008. View Article : Google Scholar : PubMed/NCBI
73.	Arends J, Zuercher G, Dossett A, Fietkau R, Hug M and Schmid I: Non-surgical oncology – Guidelines on arenteral nutrition. Ger Med Sci. 18:1–14. 2009.
74.	Pironi L, Joly F, Forbes A, et al: Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 60:17–25. 2011. View Article : Google Scholar : PubMed/NCBI
75.	Orrevall Y, Tishelman C, Herrington MK and Permert J: The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr. 23:1280–1287. 2004. View Article : Google Scholar : PubMed/NCBI
76.	Braunschweig C, Liang H and Sheean P: Indications for administration of parenteral nutrition in adults. Nutr Clin Pract. 19:255–262. 2004. View Article : Google Scholar : PubMed/NCBI
77.	Dy SM: Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care. 23:369–377. 2006. View Article : Google Scholar : PubMed/NCBI